Cell therapies are already here, with treatments now available for some cancers and rare diseases. But bringing such living medicines to more patients presents both scientific and financial challenges ...
CHICAGO--(BUSINESS WIRE)--Syntax Bio, a preclinical-stage biotechnology company, has launched with backing from Astellas Venture Management LLC and Illumina Ventures. Other investors include DCVCBio, ...
NEW YORK--(BUSINESS WIRE)--Syntax Health, Inc., an enterprise SaaS-based solution for health plans and providers that accelerates alignment in value-based care (VBC), today announced the launch of its ...
Human communication is powered by rules for combining words to generate novel meanings. Such syntactical rules have long been assumed to be unique humans. A new study, published in Nature ...
The Centers for Medicare and Medicaid Services aims to have all Medicare beneficiaries in a value-based arrangement by 2030. But achieving that will be a difficult undertaking, with just 12% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback